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Abstract
Under austerity, governments shift responsibilities for social welfare to individuals. Such responsibilization can be intertwined with
pre-existing social stigmas, with sexually stigmatized individuals blamed more for health problems due to “irresponsible” sexual
behavior. To understand how sexual stigma affects attitudes on government healthcare expenditures, we examine public support for
government-provisioned PrEP in England at a time when media narratives cast the drug as an expensive benefit for a small,
irresponsible social group and the National Health Service’s long-term sustainability was in doubt. This paper uses data from an
original survey (N = 738) conducted in September 2016, when public opinion should be most sensitive to sexual stigma. A survey
experiment tests how the way beneficiaries of PrEPwere described affected support for NHS provision of it. Contrary to expectations,
we found that support was high (mean = 3.86 on a scale of 1 to 5) irrespective of language used or beneficiary group mentioned.
Differences between conditions were negligible. Sexual stigma does not diminish support for government-funded PrEP, which may
be due to reverence for the NHS; resistance to responsibilization generally; or just to HIV, with the public influenced by sympathy and
counter-messaging. Having misjudged public attitudes, it may be difficult for the government to continue to justify not funding PrEP;
the political rationale for contracting out its provision is unnecessary and flawed. With public opinion resilient to responsibilization
narratives and sexual stigma even under austerity, welfare retrenchment may be more difficult than social policymakers presume.
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Introduction
Under neoliberal conditions of austerity, responsibility
for citizens’ health and wellbeing shifts from the state
to individuals (Adam, 2016). Governments and media
increasingly utilize “responsibilization” narratives, which
emphasize the role of individuals in managing risk to their
wellbeing, to rationalize—and facilitate—welfare state re-
trenchment (Adam, 2016). Sexual behavior is a frequent target
of responsibilization; sexual citizens deemed particularly risky
are portrayed as being at fault for their own conditions through
“irresponsible behavior” (Adam, 2016; Calabrese et al., 2016;
Hoggett, Wilkinson, & Beedell, 2013). Amidst care rationing,
government decisions on healthcare expenditures are often
controversial, but especially those concerning sexual health.
Moreover, elected officials are sensitive to public opinion on
healthcare spending. Under this backdrop, a key question
emerges that is of great import for the health and wellbeing
of sexual minorities: in times of austerity, does sexual stigma
affect public support for new government spending seen to
benefit “risky” and “irresponsible” individuals, such as gay
men? More generally, how does the framing of preventative
drugs associated with risk taking and sexual minorities affect
public attitudes on the government provision of them?
In this paper, we answer this question through the case of
National Health Service England’s (NHSE) 2016 decision to
not fund full access to the highly efficacious anti-HIV drug
pre-exposure prophylaxis (PrEP), which came amidst conten-
tious debates about the need for cutting costs to save the NHS.
Using a “most likely case” in which public opinion of
government-provisioned PrEP would expectedly be at its low-
est point and most sensitive to responsibilized views of
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perceived beneficiaries, we sought to examine whether sexual
stigma toward perceived beneficiaries changes public support
for PrEP—even in times of austerity.
This study aims to offer empirical insights about ac-
tual (rather than anticipated) public attitudes toward
PrEP in England, information that decision-makers did
not have when they chose to not fund full access to the
drug. In so doing, it fills gaps in social science research
on PrEP and research on public perception of its provi-
sion outside the US and where the drug has yet to be
made fully available (see Auerbach & Hoppe, 2015;
Baeten & Grant, 2013; Calabrese et al., 2016). It also
sheds light on the understudied political factors affecting
PrEP provision (Cáceres, O’Reilly, Mayer, & Baggaley,
2015; Underhill, Operario, Mimiaga, Skeer, & Mayer,
2010), drawing attention to how implementation of a
highly efficacious but not broadly applicable drug can be con-
tingent upon the way political institutions interpret public dis/
approval of such expenditures—especially where healthcare
is publicly funded and social spending under decline.
More broadly for sexuality and social policy, this study
contributes to our understanding of how framing of po-
tential beneficiaries and their behaviors can—and can-
not—affect public attitudes toward government health
policy decisions. It also challenges assumptions about
the public’s sensitivity to responsibilization discourses,
and the strength of these discourses in shaping their
support for government-provisioned sexual health inter-
ventions. As we illustrate, responsibilization attitudes
relating to sexuality and sexual behaviors do not appear
to run as deeply as decision-makers and media seem to
anticipate.
Theoretical and Policy Background
Public Opinion, Responsibilization, and “Risky” Sexual
Behavior
Public opinion on social programs is not only integral to the
success of the policies behind them, but also shapes citizens’
perceptions of government responsiveness and accountability;
public opinion is thereby fundamental for the legitimacy of the
welfare state itself (Bendz, 2017; Burstein, 1998; He, 2018;
Judge & Solomon, 1993; Soss, 1999). But the actual impact of
public opinion on policymaking is unclear. Some estimate that
it affects policy three quarters of the time it is measured, with
substantial effect at least a third of the time (Burstein, 2003).
The impact of public opinion on policy can be contingent on
various factors: public awareness; the clarity and size of atti-
tude shifts; issue salience and newness; and the policy process
as mediated by the institutional structure of government
(Burstein, 1998, 2003; Jacobs & Shapiro, 1994; Page &
Shapiro, 1983; Raven, Achterberg, Van der Veen, & Yerkes,
2010). To complicate matters further, policymakers do not
always have a good understanding of public opinion. As such,
its indirect effects—how policymakers anticipate public
opinion—are especially strong and factor most into how pol-
icy is crafted (Page & Shapiro, 1983; Whiteley, 1981).
On health policy, governments can be especially sen-
sitive to public opinion (Jacobs, 1992; Jacobs &
Shapiro, 1994; Judge & Hampson, 1980). When issues
are particularly controversial within the general public,
crisis-era policies have been retained to avoid public
backlash even when shown to be scientifically outdated.
For instance, decades after high-profile HIV-contaminat-
ed blood donation scandals, sexually active MSM (men
who have sex with men) still face bans on donating
blood despite the emergence of advanced blood screen-
ing technology (Galarneau, 2010). Where healthcare is
publicly funded, like in Britain, the views of the public
are even more important to consider (Judge & Solomon,
1993). Active public consultation-seeking by the NHS
and the popularity of the institution has meant that pub-
lic opinion about healthcare is an increasingly integral,
potent force in policy debates and policymaking (Harrison &
Mort, 1998; Jacobs, 1992; Judge & Solomon, 1993; Whiteley,
1981).
On policies related to sexual health, public opinion be-
comes focused less on institutions and more on individuals.
With increased emphasis on preventative health education, the
locus of responsibility for sexual health is placed heavily on
the individual, a shift corresponding to the rise of preventative
medicine more broadly (Pill & Stott, 1982) and in the context
of the shrinking welfare state in particular. For diseases like
HIV especially, individuals are believed to be responsible for
protecting themselves from contracting it (Adam, 2005,
2016), and those with HIVexpected to manage it individually
(Race, 2001). Such attitudes of responsibilization are especial-
ly prominent where sexuality is seen in normative terms and in
relation to behaviors perceived to be morally unacceptable
(Calabrese et al., 2016; Michael et al., 1998). As with MSM
“blood bans,” strong moralizing on issues of sexual behavior
is common in public health policymaking (Michael et al.,
1998) and can impede the development of more effective sex-
ual health policies. Concerns that medical advances can en-
able sexual promiscuity parallel similar concerns raised over
HAART (highly active anti-retroviral therapy) in the mid-
1990s for HIV/AIDS (Race, 2015) and oral contraceptive in
the 1960s (Auerbach & Hoppe, 2015).
Responsibilization attitudes, frequently informed by homo-
phobia and tropes of hypersexualization, are particularly prom-
inent when sexual minorities are seen as engaging in “risky”
practices. Following HIV/AIDS outbreaks globally, for in-
stance, HIV-positive gay men were seen as being “at fault”
for contracting the virus through “hedonistic” sexual behavior
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(Sabatier, 1988; Shilts, 1987). Cognizant of such attitudes in the
United States, Senate policymakers during the epidemic omit-
ted any mention of homosexuality in AIDS-related social ben-
efits policies—allowing the policies to pass without public out-
cry, and providing political face for senators in support of such
policies (Schroedel & Jordan, 1998).
In contexts like Britain, populist political discourses of
“fairness” and “deservedness” (e.g., “the deserving poor”) un-
derlying austerity measures have also influenced public opin-
ion. In particular, they heighten notions of “unacceptable”
risk, self-indulgence (see Wilson, 2007), and therefore
responsibilization on the part of marginalized groups (Cain,
2016; Hoggett et al., 2013; Roy & Buchanan, 2016). Under
such conditions, we would expect perceptions of risky sexual
behavior—and by association, sexual identities—to matter a
great deal in public opinion of sexual health policy. On the
issue of HIV, these discourses dictate that the cost of preven-
tion should be the individual’s responsibility, and not the tax-
payers’: if one cannot afford PrEP, cheaper preventative mea-
sures like condoms should be used (or one should simply
abstain from sex altogether).
Policy Background: PrEP in England
Unlike many high-income countries (and even some low- and
middle-income countries), pre-exposure prophylaxis (PrEP) is
not available to the general public across all devolved regions
in Britain. Despite a nationwide study of 544 high-risk gay
men that demonstrated the drug’s high clinical effectiveness at
preventing HIV (McCormack et al., 2015)—and the conclu-
sion of researchers that full availability of the drug could save
billions of pounds from the lifetime treatment costs for new
HIV-infected individuals (Cambiano et al., 2018)—in
June 2016, NHSE decided against providing PrEP, claiming
in part that it did not have the legal power to commission the
drug as a prevention strategy. The National AIDS Trust chal-
lenged the NHSE’s decision, winning its case in the High
Court in August 2016 and subsequently in the Court of
Appeal in November 2016 (following the NHSE’s appeal of
the initial High Court decision). However, unlike their coun-
terparts in Wales and Scotland and despite the ruling, NHSE
has yet to make the drug freely available across England.
Policy decisions like this do not occur in a vacuum and
must be examined within the current political and economic
context. Although Britons continue to strongly revere the
NHS, arguments over its funding, privatization, treatment ra-
tioning, and doctor salaries, have become increasingly divi-
sive (Campbell, 2012). Debates during the EU referendum
demonstrate how public reverence for the NHS as a British
institution has taken on a protectionist quality (Gayle, 2017;
Moore & Ramsay, 2017); promises to redirect to the NHS
£350 million bound for the EU per week were central to the
Leave campaign’s victory in the June 2016 vote (Simpkin &
Mossialos, 2017).1 While the government aims to engage in
rational, cost-effective policymaking, it is also clearly sensi-
tive to public opinion (Soroka & Lim, 2003).
Given the media response after the High Court overruled
the NHSE in August 2016, concerns of a public backlash
seemed warranted: the front page of The Daily Mail
(Britain’s most read newsbrand) derided the court for funding
a “lifestyle drug” and “promiscuity pill,”while a national tele-
vision news program led its coverage with a story on “Free
£20M drugs for gays who won’t use condoms” (Duffy, 2016).
The media narrative suggested that tax contributions used to
cover the costs of PrEP are tantamount to paying for gay men
to have unprotected sex—essentially, taxpayer-funding of “ir-
responsible” lifestyles (Cairns, 2016). The decision was
framed in zero-sum terms: giving PrEP to gay men, who are
presumably less deserving because they are victims of their
own “lifestyle” choices, takes away needed drugs from those
who are not: The Daily Mail exclaimed “NHS told to give out
£5,000-a-year lifestyle drug to prevent HIV—as vital cataract
survey is rationed” and suggested that children with cystic
fibrosis would go without treatment (Ridley, 2016). A study
of media coverage in the six most widely read newsbrands
(both online and print) from March to December 2016 found
that 79% of PrEP-related articles were published by conser-
vative leaning brands (Daily Mail, Times, Telegraph, Sun),
whereas liberal leaning Guardian and Mirror published just
13% and 8%, respectively. Thematic analyses of the coverage
found differences that corresponded with political leanings, as
well: stories on PrEP in conservative newsbrands were more
likely to mention “sexual decision making” and the financial
implications for other patient groups than those in liberal
outlets (Procter, 2017).
In its own response to the ruling, NHSE suggested that
some treatment rationing would have to occur to accommo-
date the demands of providing PrEP widely (Duffy, 2016).
This media narrative in England reflects a broader trend of
PrEP users stigmatized as irresponsible “Truvada whores”
(a reference to the brand name of the drugs used for
PrEP) (Auerbach & Hoppe, 2015; Duran, 2012; Race, 2015).
Even some within gay and HIV communities suggest PrEP is
an overly expensive excuse for continuing to engage in “irre-
sponsible” risky sexual behavior (e.g., Duran, 2012;
Weinmeyer, 2014). On the provider side, a survey of
healthcare practitioners in the US and Canada further found
1
Indeed, in Britain (but also elsewhere in Europe and the US), immigration is
becoming of increasing political concern amidst rising nationalist and ultra-
nationalist populism (NCSR, 2017). With growing anti-immigrant sentiment
in the political and public realms, the British government has pursued increas-
ingly restrictive immigration policy (Moraes, 2017; Whiteley, 1981). The
British Social Attitudes Survey found that immigration was “at the heart” of
the recent referendum vote to leave the EU (NCSR, 2017). Although in the
US, Calabrese et al. (2016) used race as a marker of the outgroup. But due to
the current political environment, non-UK born individuals were selected as an
outgroup for our study.
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that while support for providing PrEP is generally high, there
are still mixed feelings about the drug, with some expressing
“moral issues” with it and others suggesting medicine in gen-
eral should not be used to artificially reverse “bad” behaviors
(Karris et al., 2014).
Little is known about how general publics in England (or
anywhere in the world) perceive PrEP and if they support the
public provision of it. Extant literature primarily focuses on
efficacy and adherence of the drug (Baeten et al., 2012; Grant
et al., 2010). Insofar as studies examine attitudes toward PrEP,
most have focused on perceptions among providers and ben-
eficiaries (e.g., Grov & Kumar, 2018; Rocha et al., 2014;
Young, Li, & McDaid, 2013; Wheelock et al., 2012). Only
one study to date has examined general perceptions: a survey
experiment of 154 respondents in the US found that anti-
Black and anti-gay attitudes decreased support for the provi-
sion of PrEP (Calabrese et al., 2016).
Case Selection and Hypotheses
In this paper, the NHSE decision on PrEP functions as a most
likely case (Gerring, 2007); the political, economic, and media
conditions surrounding the decision were such that public
opinion on government provision of the drug would be most
likely sensitive to responsibilization narratives and sex-
ual stigma. Given low general public knowledge about
PrEP, we also expect that the public would most likely turn to
the media for cues about opinion formation, thereby increas-
ing their exposure to predominately negative media narratives
(McCombs, 2002).
The study was designed to examine how public support for
government-provisioned PrEP might differ across various
specific target populations. We are interested firstly in how
changing the target population affects general support for gov-
ernment provision of PrEP. Indeed, public support for policies
might depend on whether target groups are viewed more pos-
itively or negatively in general (Schneider & Ingram, 1993);
when the policies are seen as targeting a particularly narrow
and relatively unpopular subsection of the population they
enjoy less public support (Skocpol, 1991; Whiteley, 1981).
During the AIDS epidemic, for example, concern from
policymakers and the general public grewwhenHIVwas seen
as a virus that could attack “innocent victims,” such as young
hemophiliacs, rather than socially transgressive, “hedonistic”
gay men (Shilts, 1987, p. 225). Similarly, building upon re-
search in the US (Calabrese et al., 2016), we expect support
for funding the drug for other “outgroups” (including immi-
grants) will be lower than for the general population and those
whose stigmatized behavior is not noted (such as pregnant
women). As such, we pose our first research question: How
does framing the use and testing of a drug around specific
populations affect general support for that drug? (RQ1).
As evident in related cases of sexual moralizing in
public opinion and policymaking, support for govern-
ment funding of PrEP may further vary depending on
the degree to which those seen as primary beneficiaries
of the drug are negatively perceived on the basis of
presumed sexual behavior—and thus, responsibilized
(Herek, 2004; Lingiardi, Baiocco, & Nardelli, 2012;
Pistella, Tanzilli, Loverno, Lingiardi, & Baiocco,
2018). Here, we are concerned with sexual stigma,
which we define as negative attitudes toward any non-
heteronormative behavior, identity, or community—that
is, those which do not subscribe to the heteronormative
ideal of heterosexual monogamous coupledom. We are
interested not only in beneficiary identity but also, and
especially, how sexual behaviors being made salient—
and the degree to which they are stigmatized, particu-
larly when associated with certain group identities—
affects public support of PrEP. In the context of PrEP,
the public, media, and NHSE have generally character-
ized gay men and MSM who do not consistently use
condoms as “high risk”—and that those who admit en-
gaging in such behavior and express interest in PrEP
are somehow more irresponsible (see Race, 2015).
There is reason to assume, too, that most gay men
are seen as the “over-sexed other” even without specif-
ic evidence about individual behavior (Wilson, 2007),
and that those using this drug will be automatically
viewed as hypersexualized irrespective of their actual
behavior (Calabrese et al., 2014; Race, Lea, Murphy,
& Pienaar, 2016). This suggests a pair of separate hy-
potheses. First, we hypothesize that general support for
the provision of PrEP will decrease when perceived
beneficiaries are gay (H1)—this is an implied stigma,
separate from that of their actual behavior. Second, the
greater PrEP users are seen as “irresponsible” and en-
gaging in “high-risk” behavior, the less likely respon-
dents are to support funding (H2). This should be true
of anyone engaging in risky behaviors, regardless of
their sexual orientation.
Moreover, we are interested not just in public support of the
NHS funding PrEP in general, but also in how support may
differ for various specific potential beneficiaries of the
drug (RQ2)—that is, are respondents more or less will-
ing to support funding PrEP for different types of peo-
ple? This should also be affected by the experimental
conditions: the most obvious outcome being that people
should support the drug funded for the populations for
which they think it has been tested—that is, for the
populations to which they are exposed in their experi-
mental condition (H3). For instance, people who are
exposed to a condition highlighting testing of the drug
among pregnant women might show more support for
funding the drug for pregnant women.
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Methods
Participant Recruitment
This paper draws upon an original survey of 738 respondents
in England conducted in September 2016, which represents
the largest survey ever conducted on general public attitudes
about PrEP in the country. Participants were recruited through
Prolific, a service that matches researchers with people willing
to do small tasks online (like taking surveys) for small
amounts of money. The panel was limited to participants
who were over the age of 18, had at least a 90% approval
rating, and at least 500 jobs completed on the platform. Such
requirements are recommended as best practice when dealing
with online samples like those of Prolific or Mechanical Turk
(Peer, Vosgerau, & Acquisti, 2014).
The survey was designed to answer the research questions
outlined above, with a focus on the survey experiment element
described below. Participants gave informed consent, and
were then asked questions about PrEP (awareness of the drug,
NHS funding for different populations), diseases other than
HIV (Human Papilloma Virus and type 2 diabetes), opinions
on political issues (LGBT issues, taxes, Brexit), and
demographics.
Within this, we imbedded a survey experiment, similar to
those previously used to explore attitudes on PrEP by other
scholars in the US (Calabrese et al., 2016) and by our com-
parative research public opinion transgender policies in the
UK and US (Bode & Hildebrandt, 2018). The only difference
for each condition was what group PrEP was described as
targeting in a clinical trial. Specifically, participants were told,
“PrEP is a drug used to protect against exposure to the HIV
virus. In a recent study of approximately 500 [GROUP
INSERTED HERE], this drug was shown to be almost entire-
ly effective at preventing HIV infection when used as directed.
Based on this, would you approve or disapprove of the NHS
covering the costs of PrEP?” The groups shown were “peo-
ple” (control), “gay men,” “gay men who have frequent sex
with multiple partners,” “high risk gay men,” “people who
have frequent sex with multiple partners,” “pregnant women,”
and “non-UK born people.”
Measures and Experiments
We measure biases toward perceived beneficiary groups in
two ways. First, as described above, respondents were ran-
domly assigned to one of seven treatment groups: people
[most general, with no other descriptor] (N = 115), gay men
(N = 123), people who have frequent sex with multiple part-
ners (N = 105), gay men who have frequent sex with multiple
partners (N = 90), high-risk gay men (N = 94), non-UK born
people (N = 99), and pregnant women (N = 101). Based upon
the expectation that there would be moralizing around sex and
therefore degrees of negative bias depending on the sexual
behavior—and depending on whether the sexual behavior is
associated with gay men versus other groups—groups men-
tioning different sexual behaviors were included. Different
language was used to describe gay men, and their sexual ac-
tivity, because of an expectation that this information could
decrease support for expenditures to benefit them. Similarly,
due to an expected anti-immigrant bias, we included a treat-
ment group of non-UK born people. On the other hand, we
included pregnant women to test if they, and their unborn
children receive more public support for PrEP provision.
PrEP support is measured on a scale of 1 (strongly disapprove)
to 5 (strongly approve), with a mean of 3.86 (standard
deviation = 1.04).
The second measure of beneficiary bias comes later in the
survey, where we present all respondents with a similar list of
potential beneficiary groups and ask them to rate approval of
NHS funding for each group on a 5-point Likert scale.
Because we were not looking for changes in framing or lan-
guage, we include a slightly different list of beneficiaries of
three types: first, we include groups identified by health au-
thorities as most at risk for contracting HIV: gay men, drug
users, and sex workers (CDC, 2017; NHS, 2017); second, we
include groups which might experience positive bias
(sympathy) based on the expectation that they might be iden-
tified by the public as “innocent” populations: pregnant wom-
en and adolescents (Rochkind, DuPont, & Ott, 2009; EKOS,
2012; Shilts, 1987); finally, we include an outgroup specific to
the British research context: non-UK born people. Support for
funding varies by target population (see Table 2), with a mean
of 3.71 (standard deviation = 0.95) on a scale of 1 to 5.
Analyses and Results
A range of demographic and attitudinal information was col-
lected for respondents, including age (22.3% 18–24, 34.4%
25–34, 20.9% 35–44, 14.1% 45–54, 6.4% 55–64, 1.8% 65 or
older), gender (40.7%male, 58.8% female, .6% other or prefer
not to say), sexual orientation (91.3% heterosexual, 3.6% ho-
mosexual, gay, or queer, 4.0% other, 1.1% prefer not to say),
race and ethnicity (87.4% white, 2.4% mixed race, 6.4%
Asian/Asian British, 2.8% Black/African Caribbean/Black
British, 1.2% other ethnic group), and political ideology
(24.5% conservative, 28.3% moderate, 47.2% liberal). While
the sample is more female and younger than the UK popula-
tion as a whole, these demographics otherwise generally re-
flect the characteristics of the United Kingdom population as a
whole (Office for National Statistics, 2016).
We began by considering differences in support for PrEP
between each condition in the experiment, to answer our first
research question (RQ1). In general, we were surprised that
support for PrEP—once people are told what it is—is
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consistently high, even in the lowest support condition where
it is still well over the midpoint (see Table 1). The average
support overall is 3.86 on a scale from 1 to 5, with 44%
approving of NHS funding and an additional 29% strongly
approving. While an ANOVA [F(6, 720) = .58, p = 0.75] does
not find overall statistical significance of condition, when we
employ pairwise comparisons we find one main difference—
the lowest support is for the condition describing a study of
people who have frequent sex with multiple partners (3.73),
and the highest support is for pregnant women (4.00; p < .07).
Only these two conditions are statistically distinguishable. To
further interrogate H1, which expected that conditions men-
tioning gay people would garner lower support than those that
do not, we combine the three conditions (“gay men,” “high
risk gay men,” and “gay men who have frequent sex with
multiple partners”) that do so, and compare them to the re-
maining four conditions. This comparison shows essentially
no difference, with almost identical means (3.860 for condi-
tions mentioning gay people compared to 3.861 for those that
do not, t(420) = 0.01, p = .99). This fails to support our first
hypothesis (H1), which suggested that descriptions of PrEP
studies that dealt with gay men would garner less support than
those that did not.
Our second hypothesis suggested that mentions of risky
behavior should encourage lower support for funding PrEP.
Descriptively, there is slightly more support for this—the con-
dition that receives the least support in Table 1 is “people who
have frequent sex with multiple partners.” To formally test
this, we again combine conditions that explicitly or implicitly
mention risky behavior (“people who have frequent sex with
multiple partners,” “gay men who have frequent sex with
multiple partners,” and “high risk gay men”) and compare to
those other conditions which do not mention behaviors
at all. Again, there is very little difference whether risky
behaviors are mentioned (mean support = 3.82) or not
(mean support = 3.89, t(726) = 0.91, p = 0.36). This provides
no support for H2.2
Next, we conducted analyses to test our second research
question (RQ2) and our third hypothesis (H3), both of which
deal with support for funding the drug for specific popula-
tions. Recall respondents were asked whether they would sup-
port funding the drug for gay men, non-UK born people,
pregnant women, adolescents, drug addicts, and sex workers.
Note that these categories are similar to (gay men, non-UK
born people, pregnant women) but not entirely consistent with
the original categories of population included in the experi-
mental conditions (none of which mentioned adolescents,
drug addicts, or sex workers). In general, we expected to see
framing effects of the experimental condition to which people
were exposed—that is, those exposed to a condition relating to
a particular sub-population would be more supportive of pro-
viding the drug to that sub-population (H3). However, this
hypothesis is generally not supported by post hoc analyses.
The one exception is for pregnant women, where those ex-
posed to the condition describing PrEP as a drug for pregnant
women were significantly more likely to support use of it for
that population (p values range from 0.01 to 0.08), when com-
pared to every other condition except two (high-risk gay men
(p = 0.14) and non-UK born people (p = 0.28)).
To further answer our second research question (RQ2), we
investigated general support for funding PrEP for different
populations, which is shown in Table 2. Again, support for
providing the drug to all populations is quite high, but it is
highest for pregnant women (3.95) and lowest for non-UK
born people (3.38).
Finally, we explored what respondent characteristics were
broadly associated with support for public funding of PrEP. To
do so, we estimated an ordinary least squares regression with
PrEP support as the outcome (respondents from all conditions
were pooled together in this analysis). Because these data are
not representative of nor randomly sampled from the broader
population, results should be interpreted with caution. The
variables we considered in predicting support for PrEP in
our sample were gender (59.1% female), race (87.4% white),
Table 1 Support for funding PrEP by experimental condition
Treatment Mean
People 3.86
Gay men 3.85
High-risk gay men 3.84
Gay men who have frequent sex with multiple partners 3.89
People who have frequent sex with multiple partners 3.73
Pregnant women 4.00
Non-UK born people 3.85
The differences between conditions are not significant, with the exception
of the difference between people who have frequent sex with multiple
partners and pregnant women, which is marginally significant (p = 0.07)
2
The analysis is similar if the condition “high risky gay men”—which men-
tions risk but does not mention behavior—is reclassified. In that case, the
mean for risky behavior is 3.81 and for other conditions is 3.88,
t(726) = 0.86, p = 0.39.
Table 2 Support for funding PrEP for different populations
Population Mean level of support
Gay men 3.90
Non-UK born people 3.38
Pregnant women 3.95
Adolescents 3.71
Drug addicts 3.44
Sex workers 3.87
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age (mean = 3.5 where 3 indicates 25–34 years old and 4
indicates 35–44 years old), sexual orientation (7.7% gay or
other, 92.3% straight), political ideology (on a scale of 1 to 7,
where liberal is higher; 24.5% conservative, 28.3% moderate,
47.2% liberal), and opinion on Brexit (28.3% wanted the UK
to leave the EU, the remainder wanted the UK to stay or were
not sure).
The analysis (see Table 3 for coefficients and standard
errors) reveals several interesting predictors of PrEP support.
First, older respondents in our sample are less supportive of
funding PrEP. Those who identify as something other than
heterosexual (gay or other) are more predictive of funding
PrEP—this makes sense, as they are one population which
could particularly benefit from the drug. Finally, both political
variables are significant: those who consider themselves more
politically liberal are more likely to support public PrEP
funding, whereas those who preferred that the UK leave the
EU are significantly less supportive. It is worth noting that
despite these significant predictors, the overall model explains
only about 11% of the variance in PrEP support, suggesting
there is a great deal we do not know about what predicts
support.
Discussion
Despite strong empirical and theoretical bases for expecting
that the public would view and thus support government-pro-
visioned PrEP differently based upon the perceived ben-
eficiary, our survey experiment found no statistically
significant variation across the treatments. In fact, public
support for NHS provision of PrEP is quite high across
all treatments of the survey experiment, regardless of
perceived sexual identity or sexual behavior. To under-
stand this finding and guide future social policy re-
search, we posit four potential explanations.
First, high public support for government-provisioned
PrEP could be due to strong reverence for the NHS generally.
Surveys of the British public show a large majority strongly
believe the government has a responsibility to provide
healthcare and that the NHS should be the one number priority
for government expenditures (NCSR, 2017). The popu-
larity of the NHS in British society goes beyond what
the institution does, and centers around what it is seen
to represent: national values of social equity and collec-
tive compassion (Klein, 1985; Whiteley, 1981). The be-
lief that the NHS embodies such values might make it
difficult to reconcile denying anyone access to treat-
ment, including groups around which one holds pre-
existing sexual stigma. However, reverence can cut the
other way: tapping into these feelings, recent political
debates have stressed the need to preserve and protect
the NHS through more careful expenditure decisions in
the context of scarce funds (Cairns, 2016; Duffy, 2016;
Ridley, 2016).
Second, the finding could indicate that public opinion is not
moved by responsibilization narratives, possibly as a result of
counterflows of information exerting greater influence in the
media environment (Zaller, 1992). A 2017 study on low-
income benefits shows that arguments focusing on “lifestyle”
and personal responsibility did not always resonate with the
British public (O’Grady, 2017). Furthermore, recent surveys
suggest the British public is becomingmore socially liberal on
matters of same-sex relationships and pre-marital sex (NCSR,
2017), with a more laissez-faire view of other people’s life-
styles (NCSR, 2013). These attitude shifts might carry over to
health policy, where baseline public opinion might be more
impervious to normative lifestyle-based arguments than is
generally assumed—a hypothesis we explore in depth else-
where (Hildebrandt, Bode, & Ng, 2019). However, other
polling somewhat undercuts this explanation. A 2015 UK
survey on the use of “sin taxes” to encourage healthier life-
styles found a large majority of respondents agreed that “in-
dividuals should be responsible for their own lifestyle
choices” (Snowdon, 2015). Although a large majority of the
British public still believes healthcare should be the responsi-
bility of government, this number has fallen dramatically in
the last 5 years (NCSR, 2017), suggesting a growing percep-
tion that government’s role in healthcare should be weighed
against personal responsibility.
Third, public support for PrEPmay not be representative of
broader attitudes toward government expenditures on
healthcare, but instead unique to HIV, for a few reasons.
Targeted messaging by AIDS service organizations like
Terrence Higgins Trust—and discussion of PrEP in social
media—might have increased resistance to negative media
coverage and driven up support for government provision of
the drug. Moreover, the public remains very sympathetic to-
ward people with HIV (NAT, 2014), due in part to the
(mis)perception that their lives are “short, sad, and lonely”
(Rochkind et al., 2009). Sympathy might drive the social de-
sire to prevent this “fate” where possible in those most vul-
nerable; as shown elsewhere, sympathy can outweigh sexual
Table 3 Ordinary least
squares predicting PrEP
support among all
respondents
Variable B (SE)
Female 0.03 (0.08)
White 0.02 (0.12)
Age − 0.14 (0.03)*
Gay 0.44 (0.14)*
Liberal 0.12 (0.03)*
Brexit leave − 0.20 (0.09)*
Adjusted R2 0.11
*indicates p < 0.05
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stigma about how one’s “irresponsible” lifestyle and behavior
led to their infection (Farhat, Greene, Paige, Koblin, & Frye,
2017; Pachankis et al., 2018). Support may also be driven out
of one’s fear of becoming infected themselves. As accounts of
the AIDS crisis illustrate (Shilts, 1987), significant public con-
cern only emerged once it was understood to be a transmissi-
ble virus that could affect everyone, not just stigmatized sub-
populations. Rochkind et al. (2009) show that this fear of HIV
continues to drive people to take overly cautious measures to
protect themselves against HIV infection despite understand-
ing that these measures are irrational. Knowing that HIV is
communicable, and still linking it with historically embedded
misunderstandings of HIV as a “death sentence” (EKOS,
2012), individuals may support PrEP out of concerns for
self-preservation.
Finally, the explanation may be methodological in nature.
It is possible that our treatments were too weak to elicit reac-
tions from the participants. The changes in each condition
were small, and were not repeated, so the lack of difference
we see between conditions could be due to this, rather than
any of the previous explanations we offer.
Explanations aside, some degree of caution is needed in
interpreting our findings. In general, the extent to which
surveys can capture a real, substantial collective public
opinion is unclear (Page, 1994). Even identically
worded survey questions can yield varied responses de-
pending upon context and be primed by changing media
coverage (Judge & Solomon, 1993). Our sample is also
skewed in that it is more female and younger than the
UK population as a whole. Given that young people
and women tend to be more sexually liberal as a gen-
eral rule (though it is worth noting that a slim majority
of our respondents identify as moderate or conserva-
tive), this could meaningfully change the overall level
of support for PrEP. However, it should not affect our
findings from the experiment itself as both age and
gender are evenly distributed between all conditions
(breakdowns of gender and age by condition are avail-
able in the online appendix).
We also acknowledge that public opinion can be fickle
(Pawson & Wong, 2013). Our survey data reveal public
opinion in a particular moment in time; attitudes on
government-funded PrEP have likely shifted since the sur-
vey was conducted. But we do not believe this diminishes
the value of our results. Quite the opposite. The particular
moment in time captured in our survey actually
strengthens our findings: the survey was conducted in
September 2016 during the most sustained and negative
media coverage about PrEP in England before or since.
Under these conditions, public support of NHS-
provisioned PrEP should have been especially low and
sensitive to prejudicial attitudes, but instead we found it
to be both broad-based and quite high.
Conclusion
Using the case of the 2016 NHSE decision against funding
PrEP, we show how—contrary to expectations—sexual stig-
ma against perceived beneficiaries, even in times of austerity,
do not necessarily move public support for the government
provision of healthcare interventions seen to benefit these
groups. In fact, we find that regardless of the perceived sexual
identity and sexual behavior of potential beneficiaries,
government-funded PrEP is widely supported, once people
know about it. Insofar as NHSE’s decision to not provide
PrEP widely was due to concerns of controversy or low public
support, such fears were unfounded. This is a startling finding
for which we offered four possible explanations: denying
treatment to any group runs counter to the values of the
NHS, a revered social institution; public opinion is resilient
to responsibilization arguments; public support for PrEP is
unique to HIV rather than illustrative of a larger shift in public
attitudes to government health expenditures; and the experi-
ment was not strong enough to induce attitude shifts.
Importantly, this finding suggests policymakers may have
misjudged how the general public would perceive
government-provisioned PrEP. Moreover, such broad-based
high support for the drug might make it more difficult for
NHSE to continue justifying not funding it. Recent develop-
ments have further increased pressure on NHSE to provide
full access to PrEP: in Scotland and Wales, PrEP is already
widely available on their respective NHS’; the World Health
Organization recently declared the drug “essential” for ad-
dressing public health needs (WHO, 2017); and the UK
High Court overturned the drug patent extension for
Truvada, opening the door for generic versions of PrEP to
be available in the UK at a fraction of the cost (NAT, 2018).
NHSE’s continued failure to provide even the inexpensive
generic forms of PrEP 2 years after the patent expiration fur-
ther underscores how debates over cost-rationing and zero-
sum allocations of healthcare budgets are framed by the larger
political economy of state-protected “big pharma.”
In addition, this study has implications for how social welfare
is delivered in times of cost-cutting: fears of public outcry over
some government expenditures in times of austerity have com-
pelled policymakers to contract out service delivery to the third
sector around the world (Pownall, 2013). As in the case of PrEP
in England, such arrangements can provide arms’ length access
to public services deemed too politically costly for the state,
especially where these services are seen to benefit sexually stig-
matized groups (Būtschi & Cattacin, 1995; Hildebrandt, 2013;
Lune, 2002). Having lost their High Court case in 2016, NHSE
opted to conduct another PrEP trial, arguing that issues regard-
ing large-scale PrEP implementation are not sufficiently un-
derstood (Boseley, 2017). This second trial lasts until
September 2020; initially enrolling 10,000 participants, it
has been expanded to 26,000 places (Duffy, 2017; NHSE,
Sex Res Soc Policy
2019). But in keeping with Conservative Party-led plans to
devolve responsibility for social services from centralized au-
thorities to local communities (termed the “Big Society” under
David Cameron’s leadership), trial implementation was led by
a charity, St Stephen’s AIDS Trust. Just months into the trial,
however, St Stephen’s abruptly declared bankruptcy, jeopar-
dizing PrEP access for thousands of participants (Bowden,
2018). Our findings show the political rationale for
contracting out service provision to the third sector is some-
times not only flawed but unnecessary.
Ultimately, in countries where healthcare is publicly funded
and increasingly cost-conscious, policy decisions will always
be sensitive to public opinion. But too frequently, these deci-
sions are based more on an anticipated public response, rather
than surveys that actually measure public opinion (Page &
Shapiro, 1983; Whiteley, 1981). In this study, we have mea-
sured public attitudes in one particular case where public sup-
port for healthcare expenditures should be low and the influ-
ence of sexual stigma on attitudes high—and find that the actual
public opinion was quite different than anticipated. While we
do not suggest that sexual stigma and responsibilization narra-
tives do not matter at all—evidence has shown that such polit-
ically led discourses have indeed moved public opinion in
Britain (Hoggett et al., 2013; O’Grady, 2017)—this study
draws into question assumptions about their strength. On cer-
tain social policy issues such as health expenditures and even
in times of austerity, public opinion may be more resilient to
sexual stigma and responsibilization—an area which requires
further exploration.
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